The Role of the CTLA4 Blockade in the Treatment of Malignant Melanoma

By Cranmer Lee   Hersh Evan  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 613-631

Informa Healthcare

Access to resources Recommend Favorite

Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study

By Queirolo P.  

Cancer Investigation, Vol. 31, Iss. 5, 2013-06 ,pp. : 336-345

Informa Healthcare

Access to resources Recommend Favorite

Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 105-113

Bentham Science Publishers

Access to resources Recommend Favorite

Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma model

By Chen Zubing   Shen Shiqiang   Peng Baogang   Tao Jianpin  

International Journal of Hyperthermia, Vol. 25, Iss. 5, 2009-08 ,pp. : 374-382

Informa Healthcare

Access to resources Recommend Favorite

Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity

By Simmons Andrew   Moskalenko Marina   Creson Jennifer   Fang Jianmin   Yi Saili   VanRoey Melinda   Allison James   Jooss Karin  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 8, 2008-08 ,pp. : 1263-1270

Springer Publishing Company

Access to resources Recommend Favorite